Beta Bionics Inc
NASDAQ:BBNX
Intrinsic Value
The intrinsic value of one BBNX stock under the Base Case scenario is 11.46 USD. Compared to the current market price of 14.43 USD, Beta Bionics Inc is Overvalued by 21%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Beta Bionics Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Beta Bionics Inc
Balance Sheet Decomposition
Beta Bionics Inc
Current Assets | 132.9m |
Cash & Short-Term Investments | 103.6m |
Receivables | 12m |
Other Current Assets | 17.4m |
Non-Current Assets | 16.7m |
PP&E | 11.4m |
Other Non-Current Assets | 5.3m |
Free Cash Flow Analysis
Beta Bionics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Beta Bionics Inc
Revenue
|
65.1m
USD
|
Cost of Revenue
|
-29.2m
USD
|
Gross Profit
|
35.9m
USD
|
Operating Expenses
|
-81.1m
USD
|
Operating Income
|
-45.3m
USD
|
Other Expenses
|
-9.5m
USD
|
Net Income
|
-54.8m
USD
|
BBNX Profitability Score
Profitability Due Diligence
Beta Bionics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Beta Bionics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
BBNX Solvency Score
Solvency Due Diligence
Beta Bionics Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Beta Bionics Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BBNX Price Targets Summary
Beta Bionics Inc
According to Wall Street analysts, the average 1-year price target for BBNX is 26.23 USD with a low forecast of 18.18 USD and a high forecast of 31.5 USD.
Dividends
Current shareholder yield for BBNX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one BBNX stock under the Base Case scenario is 11.46 USD.
Compared to the current market price of 14.43 USD, Beta Bionics Inc is Overvalued by 21%.